McKesson
MCK
#197
Rank
NZ$185.88 B
Marketcap
NZ$1,506
Share price
0.60%
Change (1 day)
28.15%
Change (1 year)
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.

EPS for McKesson (MCK)

EPS in 2025 (TTM): NZ$60.12

According to McKesson's latest financial reports the company's current EPS (TTM) is NZ$60.77. an increase over its 2024 EPS that were of NZ$38.22.

EPS history for McKesson from 2014 to 2025

Annual EPS

Year EPS Change
2025NZ$60.5158.33%
2024NZ$38.22-1.17%
2023NZ$38.671%
2022NZ$38.29144.72%
2021NZ$15.65-133.49%
2020NZ-$46.71451.13%
2019NZ-$8.48266.17%
2018NZ-$2.31-105.85%
2017NZ$39.58166.28%
2016NZ$14.860.71%
2015NZ$14.7614.44%
2014NZ$12.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Cerner
CERN
NZ$3.48-94.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Henry Schein
HSIC
NZ$5.74-90.55%๐Ÿ‡บ๐Ÿ‡ธ USA
AmerisourceBergen
ABC
NZ$14.43-76.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
NZ$12.17-79.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
NZ-$0.47-100.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Patterson Companies
PDCO
NZ$2.72-95.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Computer Programs and Systems
CPSI
NZ-$5.48-109.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Veradigm
MDRX
NZ$0.87-98.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Owens & Minor
OMI
NZ-$30.29-149.84%๐Ÿ‡บ๐Ÿ‡ธ USA